• Isoprinosine in Immunotherapy: Optimizing Antiviral Workflow

  2026-05-14

  Isoprinosine (inosine pranobex) bridges immune modulation and targeted antiviral action, enabling robust viral inhibition and enhanced immunotherapy. This article delivers stepwise protocols, troubleshooting, and the latest translational insights for researchers tackling herpesvirus and acute respiratory infection models.

• Thapsigargin: Precision SERCA Pump Inhibition for ER Stress

  2026-05-14

  Thapsigargin is a potent SERCA pump inhibitor that precisely disrupts intracellular calcium homeostasis, making it a cornerstone tool for endoplasmic reticulum (ER) stress and apoptosis research. APExBIO’s Thapsigargin (SKU B6614) offers reproducible performance, with documented nanomolar efficacy in cell-based and animal models. Its mechanism, benchmarks, and boundaries are well-demarcated by peer-reviewed evidence.

• Hexa-Acylated LPS from Gut Microbiota Enhances Immunotherapy

  2026-05-13

  This study demonstrates that gut microbiota-derived hexa-acylated lipopolysaccharides (LPS) are critical enhancers of anti-PD-1 cancer immunotherapy response. By functionally analyzing patient microbiomes and using in vivo tumor models, the authors show LPS structure—not just microbial taxonomy—determines immunostimulatory potential, with implications for both mechanistic research and clinical translation.

• AICAR Applications: AMPK Activation for Metabolic Disease Re

  2026-05-13

  AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) empowers metabolic disease and cellular stress research with robust, reproducible AMPK activation. This guide translates cutting-edge findings—like TRPV1-AMPK pathway modulation—into actionable protocols, troubleshooting insights, and advanced workflow enhancements.

• Polyvalent Vaccines Target Tumor-Associated Bacteria to Limi

  2026-05-12

  Kang et al. present a polyvalent vaccine strategy that selectively eliminates tumor-associated bacteria, demonstrating significant reduction in breast cancer metastasis in preclinical models. This approach highlights the therapeutic potential of microbiome modulation in cancer progression and offers a framework for immune-based targeting of intratumoral pathogens.

• HCN4 Channels Mediate Heart Rate Response to Heat via S4-S5

  2026-05-12

  Wu et al. identified a conserved S4-S5 linker motif in HCN4 channels as essential for the cardiac pacemaker response to heat, independent of the cyclic nucleotide binding domain. This finding clarifies the molecular basis of heat-induced heart rate increases and suggests broader roles for HCN channels in thermal sensing, informing future cardiac and excitable cell research.

• Dehydroepiandrosterone (DHEA): Mechanism, Evidence & Limits

  2026-05-11

  Dehydroepiandrosterone (DHEA) is a well-characterized endogenous steroid and neuroprotection agent, supporting apoptosis inhibition and ovarian granulosa cell studies. Quantitative evidence demonstrates DHEA’s dose-responsive efficacy in neuronal and ovarian models. This article details mechanistic facts, protocol parameters, and verified boundaries for research applications.

• Nicotine Signaling Accelerates CKD Progression via nAChRs

  2026-05-11

  This literature-focused review examines the mechanisms by which nicotine, a key component of cigarette smoke, exacerbates chronic kidney disease (CKD) progression through non-neuronal nicotinic acetylcholine receptor (nAChR) signaling. The findings highlight the potential for targeted anti-lymphangiogenic strategies and support the use of selective VEGFR-3 inhibitors in related research models.

• Optimizing Blood Sample Prep with Red Blood Cell Lysis Buffe

  2026-05-10

  Red Blood Cell Lysis Buffer streamlines mammalian blood sample preparation by efficiently removing erythrocytes while preserving nucleated cells. Integration with advanced workflows, including osteoblast differentiation studies, ensures high assay sensitivity and reproducibility—key for downstream molecular and cytometric applications.

• O-GlcNAcylation Links Wnt Signaling to Osteoblast Metabolism

  2026-05-09

  This study reveals that O-GlcNAcylation is critical for Wnt-induced bone formation by directly modulating aerobic glycolysis in osteoblasts. The work identifies a dual mechanism of Wnt3a-driven O-GlcNAcylation, with direct implications for understanding metabolic control in skeletal biology and for designing targeted Wnt pathway interventions.

• BCECF-AM: Ratiometric Intracellular pH Dye for Live-Cell Ass

  2026-05-08

  BCECF-AM is a robust, cell membrane-permeable fluorescent probe for precise intracellular pH measurement. This article details its mechanism, benchmarking, and practical parameters in plant and mammalian systems, with evidence from primary sources and APExBIO product documentation.

• BRD4 Inhibition Enhances Erastin-Induced Ferroptosis via ROS

  2026-05-08

  This study demonstrates that BRD4 inhibitors, including I-BET-762, significantly enhance erastin-induced ferroptosis across diverse cell lines by promoting reactive oxygen species (ROS) accumulation and downregulating FSP1. These findings clarify the mechanistic interplay between BET inhibition and ferroptotic sensitivity, supporting new directions in cancer biology and translational research.

• Niclosamide (SKU B2283): Precision STAT3/NF-κB Inhibition in

  2026-05-07

  This article delivers a scenario-driven, evidence-based exploration of Niclosamide (SKU B2283) for cell viability, apoptosis, and STAT3/NF-κB pathway assays in cancer research. Researchers and lab technicians will find protocol guidance, troubleshooting insights, and practical vendor selection advice, all grounded in peer-reviewed literature and real-world laboratory workflow challenges.

• YTHDC1 Regulates Autophagy via SQSTM1 mRNA Stability in Diab

  2026-05-07

  This study identifies the m6A reader YTHDC1 as a key regulator of autophagy in diabetic skin by modulating the stability of SQSTM1 mRNA. Loss of YTHDC1 impairs autophagic flux and delays wound healing, providing mechanistic insight into diabetes-associated repair defects.

• Dibutyryl-cAMP, Sodium Salt: Elevating cAMP Pathway Research

  2026-05-06

  Dibutyryl-cAMP, sodium salt (DBcAMP sodium salt) enables high-fidelity manipulation of cAMP signaling in cell-based assays, transforming workflows from neural reprogramming to inflammation modulation studies. This article delivers actionable protocol guidance, troubleshooting expertise, and evidence-based comparative insights, establishing APExBIO’s product as an indispensable asset for advanced cAMP research.

15528 records 1/1036 page Next 12345 下5页 Last page